Precision Medicine

CytoReason, a leader and pioneer in computational disease modeling, announced an expansion of its collaboration with Sanofi. The multiyear…

Tempus, a leader in artificial intelligence and precision medicine, announced a prospective study , in collaboration with AstraZeneca , that aims to…

Perceiv AI announced the closing of an investment of $1.5 Million. Perceiv AI is a precision medicine company optimizing and de-risking clinical…

Effort aligns MD Anderson’s drug development expertise with Exscientia’s AI-driven patient-first precision medicine and drug discovery platforms…

PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, announced that the organization’s recent research will be…

In collaboration with iRhythm, Tempus is studying its predictive, AI-enabled algorithmic tests via a network of researchers to determine the…

Tempus, a leader in artificial intelligence and precision medicine, announced a new collaboration sponsored by Eli Lilly and Company designed to…

Collaborations demonstrate role as a core partner in multidisciplinary cancer care From early detection to remote monitoring and data…

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment for oncology, and…

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and Ochsner Health (Ochsner) announced a multi-faceted…